|
| 37823831 | Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium. | Cancer Discov | 2024 |
| 37480151 | Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer. | Cell Biosci | 2023 |
| 36335802 | The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science. | Neoplasia | 2023 |
| 37726477 | Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives. | Br J Cancer | 2023 |
| 37683275 | Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas. | | 2023 |
| 37075810 | LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients. | Neuro Oncol | 2023 |
| 37013636 | A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer. | Genome Med | 2023 |
| 36882456 | Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes. | Sci Rep | 2023 |
| 37382186 | Parents' expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial. | Cancer | 2023 |
| 37124503 | BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience. | Front Oncol | 2023 |
| 37001527 | Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities. | Cancer Cell | 2023 |
| 37376781 | Parents' and adolescents' perspectives and understanding of information about childhood cancer precision medicine. | Cancer | 2023 |
| 36937401 | <i>In vivo</i> loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma. | Front Oncol | 2023 |
| 37178647 | Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial. | Eur J Cancer | 2023 |
| 37523146 | High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer. | Cancer Res | 2023 |
| 37517472 | Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study. | J Mol Diagn | 2023 |
| 37511646 | Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine Trial. | J Pers Med | 2023 |
| 35148393 | Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry. | Neuro Oncol | 2022 |
| 36358729 | Quality of Life (QoL) of Children and Adolescents Participating in a Precision Medicine Trial for High-Risk Childhood Cancer. | Cancers | 2022 |
| 36167468 | GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma. | Journal for ImmunoTherapy of Cancer | 2022 |
| 35832071 | Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy. | Theranostics | 2022 |
| 36013276 | What's in a Name? Parents' and Healthcare Professionals' Preferred Terminology for Pathogenic Variants in Childhood Cancer Predisposition Genes. | J Pers Med | 2022 |
| 36215217 | Phase 1b study of carfilzomib with induction chemotherapy in pediatric relapsed/refractory acute lymphoblastic leukemia. | Pediatric Blood and Cancer | 2022 |
| 35999452 | Parents' understanding of genome and exome sequencing for pediatric health conditions: a systematic review. | Eur J Hum Genet | 2022 |
| 35552452 | Characteristics of children ⿤36 months of age with DIPG: A report from the international DIPG registry. | Neuro Oncol | 2022 |
| 35802025 | FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits. | Cancer Res | 2022 |
| 35989458 | Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR). | Pediatr Blood Cancer | 2022 |
| 36582791 | Resistance mechanisms in BRAF paediatric high-grade glioma and current therapeutic approaches. | | 2022 |
| 34166569 | Barriers and potential solutions to international collaboration in neuro-oncology clinical trials: Challenges from the Australian perspective. | Asia-Pacific Journal of Clinical Oncology | 2022 |
| 34992263 | Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency. | Nat Med | 2022 |
| 34850167 | Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors. | Neuro Oncol | 2022 |
| 34668975 | Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry. | Neuro Oncol | 2022 |
| 35180323 | Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium. | Am J Hematol | 2022 |
| 34944870 | Therapeutic Targets in Diffuse Midline Gliomas-An Emerging Landscape. | Cancers | 2021 |
| 32267508 | Diagnostic Yield of Initial and Consecutive Blood Cultures in Children With Cancer and Febrile Neutropenia. | Journal of the Pediatric Infectious Diseases Society | 2021 |
| 33486006 | Frontiers in the treatment of glioblastoma: Past, present and emerging. | Advanced Drug Delivery Reviews | 2021 |
| 33805713 | Doxorubicin-Loaded Gold Nanoarchitectures as a Therapeutic Strategy against Diffuse Intrinsic Pontine Glioma. | Cancers | 2021 |
| 33852836 | Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG. | Cell Rep | 2021 |
| 33580196 | Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor. | NPJ Precis Oncol | 2021 |
| 33579942 | Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas. | Nat Commun | 2021 |
| 33890721 | Copper: An Intracellular Achilles' Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics. | ChemMedChem | 2021 |
| 33996584 | Malignant Melanoma in Children and Adolescents Treated in Pediatric Oncology Centers: An Australian and New Zealand Children's Oncology Group (ANZCHOG) Study. | Front Oncol | 2021 |
| 33994371 | Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma. | Clin Cancer Res | 2021 |
| 33945292 | Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance. | J Clin Oncol | 2021 |
| 34298664 | Development of Randomized Trials in Adults with Medulloblastoma-The Example of EORTC 1634-BTG/NOA-23. | Cancers (Basel) | 2021 |
| 33918978 | A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma. | Cancers (Basel) | 2021 |
| 33355208 | DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells. | Cancer Discov | 2021 |
| 32971146 | Gastrointestinal Hemorrhage: A Manifestation of the Telomere Biology Disorders. | J Pediatr | 2021 |
| 34572932 | Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma. | Cancers (Basel) | 2021 |
| 34458732 | Parents' experiences of postmortem tumor donation for high-grade gliomas: benefits and suggested improvements. | Neuro-Oncology Advances | 2021 |